Published in J Nanobiotechnology on February 24, 2010
Nanoparticles for retinal gene therapy. Prog Retin Eye Res (2010) 0.95
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev (2016) 0.84
Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery. Int J Nanomedicine (2015) 0.76
Composite nanoparticles for gene delivery. Adv Genet (2014) 0.75
Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications. Biomater Res (2016) 0.75
Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med (2008) 17.21
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med (2006) 9.68
The basic science of gene therapy. Science (1993) 5.94
Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev (1997) 5.73
Nonviral vectors for gene delivery. Chem Rev (2009) 4.08
Side effects of retroviral gene transfer into hematopoietic stem cells. Blood (2003) 2.35
Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther (2007) 1.94
AIDS research. Did Merck's failed HIV vaccine cause harm? Science (2007) 1.71
Cationic liposome-mediated gene transfer. Gene Ther (1995) 1.68
Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci U S A (2000) 1.63
Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther (2004) 1.55
Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol (2009) 1.40
Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther (1997) 1.36
Improving the transfection efficiency of post-mitotic neurons. J Neurosci Methods (2001) 1.29
Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidable. Semin Hematol (2004) 1.22
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther (2006) 1.18
Evaluation of polyplexes as gene transfer agents. J Control Release (2001) 1.16
Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII. Blood (2003) 1.15
Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther (2005) 1.15
Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. J Control Release (1998) 1.08
Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis (2005) 1.06
Cationic liposome-mediated intravenous gene delivery. J Biol Chem (1995) 1.05
Characterization of drug-loaded poly(d,l-lactide) microspheres. J Pharm Sci (1984) 0.99
Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther (2002) 0.99
Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther (2000) 0.98
Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo. J Virol (2009) 0.97
In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma. J Gene Med (2009) 0.91
Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells. Hum Gene Ther (1998) 0.89
Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. Biopolymers (2007) 0.89
Electroporation advances in large animals. Curr Gene Ther (2009) 0.87
Adeno-associated virus-based vectors in gene therapy. J Biomed Sci (2000) 0.87
Next-generation adenoviral vectors: new and improved. Gene Ther (1999) 0.86
No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. J Appl Physiol (1985) (1994) 0.85
Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. Acta Physiol Scand (2002) 0.85
Formulations for DNA delivery via electroporation in vivo. Methods Mol Biol (2008) 0.82
Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine). Biomaterials (2008) 0.82
Gene therapy. What to do when clear success comes with an unclear risk? Science (2002) 0.82
Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances. Expert Opin Drug Deliv (2009) 0.81
Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation. J Pharm Pharmacol (2008) 0.81
Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation. Graefes Arch Clin Exp Ophthalmol (2000) 0.81
Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles. Drug Dev Ind Pharm (2008) 0.80
Gene delivery to the neurulating embryo during culture. Teratology (1999) 0.78
Increased non-viral gene transfer levels in mice by concentration of cationic lipid DNA complexes formed under optimized conditions. J Gene Med (2003) 0.78
Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo. J Mol Med (Berl) (2001) 0.77
Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol (2006) 9.95
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet (2010) 7.11
Clinical empathy as emotional labor in the patient-physician relationship. JAMA (2005) 4.56
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors. J Clin Invest (2014) 3.54
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet (2013) 1.87
Interaction dynamics of neuronal oscillations analysed using wavelet transforms. J Neurosci Methods (2006) 1.52
Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression. J Immunol (2013) 1.50
From autonomy to creativity: a multilevel investigation of the mediating role of harmonious passion. J Appl Psychol (2011) 1.49
Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One (2012) 1.44
Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem (2012) 1.33
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine (2011) 1.27
Gene selection algorithms for microarray data based on least squares support vector machine. BMC Bioinformatics (2006) 1.21
Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol (2011) 1.20
Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother (2013) 1.12
Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul (2007) 1.11
Meta-Heuristic Combining Prior Online and Offline Information for the Quadratic Assignment Problem. IEEE Trans Cybern (2013) 1.08
Influence of algal bloom degradation on nutrient release at the sediment-water interface in Lake Taihu, China. Environ Sci Pollut Res Int (2012) 1.04
Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med (2009) 1.03
Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One (2012) 1.02
Tryptophan-based peptides to synthesize gold and silver nanoparticles: a mechanistic and kinetic study. Chemistry (2007) 1.00
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol (2012) 1.00
In situ amplified chemiluminescent detection of DNA and immunoassay of IgG using special-shaped gold nanoparticles as label. Clin Chem (2006) 1.00
The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS One (2013) 1.00
Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther (2015) 0.99
Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol (2013) 0.99
Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer (2005) 0.99
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial. J Infect Dis (2013) 0.99
Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients. J Cell Mol Med (2012) 0.99
High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma. Int J Clin Oncol (2012) 0.98
Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes. Mol Ther (2012) 0.98
The redox-sensing regulator Rex modulates central carbon metabolism, stress tolerance response and biofilm formation by Streptococcus mutans. PLoS One (2012) 0.96
Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics. Front Biosci (2002) 0.94
Probabilistic classification vector machines. IEEE Trans Neural Netw (2009) 0.93
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36. J Acquir Immune Defic Syndr (2014) 0.92
A new approach for analyzing average time complexity of population-based evolutionary algorithms on unimodal problems. IEEE Trans Syst Man Cybern B Cybern (2009) 0.92
Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer (2004) 0.91
Establishment of an aging model of Sca-1+ hematopoietic stem cell and studies on its relative biological mechanisms. In Vitro Cell Dev Biol Anim (2010) 0.91
Synchronization measurement of multiple neuronal populations. J Neurophysiol (2007) 0.90
Novel ascorbic acid based ionic liquids for the in situ synthesis of quasi-spherical and anisotropic gold nanostructures in aqueous medium. Chemistry (2008) 0.90
Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. Vaccine (2005) 0.90
Direct electrochemistry of glucose oxidase and electrochemical biosensing of glucose on quantum dots/carbon nanotubes electrodes. Biosens Bioelectron (2007) 0.90
Ascorbate-assisted growth of hierarchical ZnO nanostructures: sphere, spindle, and flower and their catalytic properties. Langmuir (2010) 0.89
Development and optimization of nanosomal formulations for siRNA delivery to the liver. Eur J Pharm Biopharm (2011) 0.89
Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants. Pediatr Infect Dis J (2012) 0.89
Magnetic quantum oscillations in YBa2Cu3O6.61 and YBa2Cu3O6.69 in fields of up to 85 T: patching the hole in the roof of the superconducting dome. Phys Rev Lett (2010) 0.88
Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model. J Virol (2007) 0.88
High-glucose-induced endothelial cell injury is inhibited by a Peptide derived from human apolipoprotein E. PLoS One (2012) 0.88
CCL11 as a potential diagnostic marker for asthma? J Asthma (2014) 0.87
Enterovirus 71 viral capsid protein linear epitopes: identification and characterization. Virol J (2012) 0.87
A new adaptive merging and growing algorithm for designing artificial neural networks. IEEE Trans Syst Man Cybern B Cybern (2009) 0.86
SATB1 is required for CD8 coreceptor reversal. Mol Immunol (2008) 0.86
A constructive algorithm for training cooperative neural network ensembles. IEEE Trans Neural Netw (2003) 0.86
Intravascular large B-cell lymphoma, an exclusively small vessel disease? A case report and review of literature. Leuk Res (2010) 0.86
Expression of T-cell immunoglobulin- and mucin-domain-containing molecule-1 (TIM-1) is increased in a mouse model of asthma and relationship to GATA-3. Life Sci (2007) 0.86
Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats. World J Gastroenterol (2005) 0.86
A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis. PLoS One (2011) 0.86
HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers. Virol J (2005) 0.85
Hydrophilic interaction ultra-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry for highly rapid and sensitive analysis of underivatized amino acids in functional foods. Amino Acids (2013) 0.85
Exhaled carbon monoxide in asthmatics: a meta-analysis. Respir Res (2010) 0.85
Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help. Vaccine (2006) 0.85
Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice. Immunol Lett (2012) 0.85
Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71. PLoS One (2013) 0.84
Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of pentamidine microcapsules. Int J Pharm (2004) 0.84
A note on problem difficulty measures in black-box optimization: classification, realizations and predictability. Evol Comput (2007) 0.84
Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma. Urology (2012) 0.84
Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles. J Pharm Pharmacol (2010) 0.83
Application of fullerenes in nanomedicine: an update. Nanomedicine (Lond) (2013) 0.83
Psr is involved in regulation of glucan production, and double deficiency of BrpA and Psr is lethal in Streptococcus mutans. Microbiology (2013) 0.83
Stability of lyophilized siRNA nanosome formulations. Int J Pharm (2011) 0.83
Cellular delivery of PEGylated PLGA nanoparticles. J Pharm Pharmacol (2011) 0.83
Stable superhydrophobic surface of hierarchical carbon nanotubes on Si micropillar arrays. Nanoscale Res Lett (2013) 0.83
Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol (2013) 0.83
Statins as potential therapeutic drug for asthma? Respir Res (2012) 0.83
Correlation between catalytic activity and surface ligands of monolayer protected gold nanoparticles. J Colloid Interface Sci (2011) 0.83
Development of nanosomes using high-pressure homogenization for gene therapy. J Pharm Pharmacol (2010) 0.83
Adenovirus-mediated overexpression of novel mutated IkappaBalpha inhibits nuclear factor kappaB activation in endothelial cells. Chin Med J (Engl) (2005) 0.83
Portal hypertension caused by right common iliac artery-superior mesenteric vein fistula. Jpn J Radiol (2015) 0.82
Evolutionary and principled search strategies for sensornet protocol optimization. IEEE Trans Syst Man Cybern B Cybern (2011) 0.82
Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice. PLoS One (2011) 0.82
Hairpin DNA probe based electrochemical biosensor using methylene blue as hybridization indicator. Biosens Bioelectron (2006) 0.82
Variability in HIV-1 partial genomic sequences in Costa Rican patients: analysis with different bioinformatics tools. Rev Panam Salud Publica (2010) 0.82
Covalent organic frameworks formed with two types of covalent bonds based on orthogonal reactions. J Am Chem Soc (2015) 0.82
The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells. Virology (2007) 0.82
Determination of human cytomegalovirus genetic diversity in different patient populations in Costa Rica. Rev Inst Med Trop Sao Paulo (2004) 0.82
Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α. J Biol Chem (2014) 0.81
Alternate delivery route for amifostine as a radio-/chemo-protecting agent. J Pharm Pharmacol (2008) 0.81
EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer. Med Oncol (2013) 0.81
Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer. Med Oncol (2014) 0.81
High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations. J Med Virol (2005) 0.81
Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation. J Pharm Pharmacol (2008) 0.81
Neuronal population oscillations of rat hippocampus during epileptic seizures. Neural Netw (2008) 0.81
Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects. PLoS One (2013) 0.81
Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD). J Immune Based Ther Vaccines (2004) 0.81
[Changes of telomere and telomerase in effect of ginsenoside Rg1 to delay hematopoietic stem cell senescence]. Zhongguo Zhong Yao Za Zhi (2011) 0.81
Immunization with HBsAg-Fc fusion protein induces a predominant production of Th1 cytokines and reduces HBsAg level in transgenic mice. Chin Med J (Engl) (2012) 0.81
Chemiluminescence of CdTe nanocrystals induced by direct chemical oxidation and its size-dependent and surfactant-sensitized effect. J Phys Chem B (2005) 0.81
Semisupervised classification with cluster regularization. IEEE Trans Neural Netw Learn Syst (2012) 0.81
pH-controlled reversible assembly of peptide-functionalized gold nanoparticles. Langmuir (2007) 0.81